respiratory fluoroquinolone
Jump to navigation
Jump to search
Introduction
fluoroquinolones with reliable activity against Streptococcus pneumoniae, including:
Adverse effects
- respiratory fluoroquinolones associated with increased risk of sudden cardiac death vs amoxicillin in patients on hemodialysis[1]
More general terms
More specific terms
- gatifloxacin (Tequin, Zymar)
- gemifloxacin (Factive)
- grepafloxacin (Raxar)
- levofloxacin (Levaquin)
- moxifloxacin (Avelox, Vigamox)
- sparfloxacin (Zagam)
- trovafloxacin (Trovan)
References
- ↑ 1.0 1.1 Assimon MM, Pun PH, Wang L et al Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol. Published online October 20, 2021 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34668928 https://jamanetwork.com/journals/jamacardiology/fullarticle/2785156